Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of ...
The biotech bi-weekly: innovative model platforms, AI-optimized biotherapeutics and science in space
In this edition of the biotech bi-weekly, catch up on five innovative product launches – from lab balances to spatial solutions – and recent partnerships driving human health forward. Illumina (CA, ...
A new study discovers a critical microglial cell transition that determines whether Alzheimer’s pathology causes dementia.
Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics have uncovered a critical biological transition that may ...
Muna Therapeutics, a clinical-stage biotechnology company pioneering a new era of drug discovery for neurodegenerative ...
Recent advances in single-cell biology, spatial transcriptomics, multi-omics integration, artificial intelligence, and biosensor engineering are ...
GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
Leuven, 4 June 2026 – Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether ...
Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical ...
The integration of artificial intelligence (AI) and multi-omics analysis is rapidly transforming the landscape of drug research and development. In recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results